AI Drug Development Stocks Rally Early in Trading, METIS TECHBIO-P Jumps Over 13%, INWISEAI Up More Than 11%

Deep News
8小時前

Shares of companies focused on AI-driven pharmaceutical development experienced a broad uptick during the morning session, with several key players posting significant gains.

At the time of reporting, METIS TECHBIO-P (07666) surged by 13.20%, trading at HK$17.58, while INWISEAI (03696) climbed 10.98% to HK$59.65. Meanwhile, XtalPi Holdings (02228) advanced 8.34% to HK$7.47, and GenScript Biotech (01548) rose 6.39% to HK$39.60.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10